Navigation Links
Market Forecasts: Seasonal Influenza Vaccines
Date:9/20/2012

NEW YORK, Sept. 20, 2012 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Market Forecasts: Seasonal Influenza Vaccines

http://www.reportlinker.com/p0968570/Market-Forecasts-Seasonal-Influenza-Vaccines.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication

The large public attention associated with the influenza A (H1N1, swine flu) pandemic in 2009 increased awareness of the importance of seasonal influenza vaccination. Datamonitor predicts that the seasonal influenza vaccine market will grow to $4.7bn by 2021/22, and will be driven by changes in national recommendations to include additional target populations, particularly children.Quantifies the predicted number of people eligible for seasonal influenza vaccination across the seven major markets.Provides detailed sales forecasts for each of the seven major markets based on the expected coverage rates for different population groups.Explains the major growth drivers in the seasonal influenza vaccine market, including predicted changes to national recommendations.Identifies which markets provide the greatest opportunity for growth.

Over the forecast period, the seasonal influenza vaccine market in the seven major markets is set to increase from combined sales of $3.6bn in 2011/12 to $4.7bn in 2021/22. Growth is driven by a broadening of recommendations across the seven major markets and by increased awareness of the benefits of influenza vaccination.

The US is the largest single market for influenza vaccines, and growth has been driven by price increases, increased coverage rates after the 2009 influenza pandemic, and the introduction of a universal recommendation in 2010. Campaigning by US authorities will continue to increase coverage rates; however, growth is expected to slow.

Datamonitor predicts that each of the five major EU markets will include children aged <5 years and school-aged children between five and 17 years in their national recommendations, substantially increasing the number of people eligible for vaccination during the forecast period.

How was the seasonal influenza vaccine market affected by the 2009 influenza A (H1N1, swine flu) pandemic?Which countries are predicted to broaden recommendations for influenza vaccination over the next 10 years?How many people are eligible for influenza vaccination in each of the seven major markets?How will sales of seasonal influenza vaccines evolve for each market during the forecast period?Which of the seven major markets provides the greatest opportunity for growth?

OVERVIEW•Summary

PRODUCT OVERVIEW•Introduction

•Features and benefits

•Research and analysis highlights

•Key questions answered

•Forecast methodology and assumptions

•Disclaimer

Companies MentionedHutchison 3G UK LimitedTo order this report:Drug_and_Medication Industry: Market Forecasts: Seasonal Influenza Vaccines

Nicolas Bombourg
Reportlinker
Email: nicolasbombourg@reportlinker.com
US: (805)652-2626
Intl: +1 805-652-2626


'/>"/>
SOURCE Reportlinker
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Rapid Fire Marketing Funds Development of Second Generation Vapor Inhaler
2. ulrich medical USA™ Releases New Expandable Spinal Implant for US Market
3. Nektar to Announce Financial Results for the First Quarter of 2012 on Wednesday, May 2, 2012, After Close of U.S.-Based Financial Markets
4. Almost 50 Percent of the Glaucoma Patient Population Remains Untreated, Signifying a Vast Market for Glaucoma Pharmaceuticals, Finds Frost & Sullivan
5. International Drug & Explosives Detection Company IDenta Corp. Releases Information to OTC markets.
6. Althea Technologies Appoints Dr. Kristin DeFife, Director, Biologics Manufacturing And Jack Wright, VP, Sales and Marketing
7. Ophthalmic Drugs: World Market Prospects 2012-2022
8. OTC Pharmaceuticals: Global Industry Almanac, MarketLine
9. ResearchMoz: The World Anesthesia Drug Market (General, Local, Adjunctive) - Market Research Report
10. Endocrinology Market to 2018 - Advanced Injection Devices for Growth Hormone and Somatostatin will Improve Ease of Use for Patients
11. Cara Therapeutics Licenses Novel Kappa Opioid Agonist, CR845, to Chong Kun Dang Pharmaceutical Corporation For South Korean Market
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... , June 24, 2016  Global Blood ... biopharmaceutical company developing novel therapeutics for the treatment ... today announced the closing of its previously announced ... stock, at the public offering price of $18.75 ... offering were offered by GBT. GBT estimates net ...
(Date:6/24/2016)... DUBLIN , June 24, 2016 ... addition of the "Structural Electronics 2015-2025: Applications, ... In-Mold Electronics, Smart ... Integrated Photovoltaics Structural electronics involves ... as load-bearing, protective structures, replacing dumb structures such ...
(Date:6/24/2016)... and SAN CLEMENTE, Calif. , June 24, ... -based mobile pulmonary function testing company, is now able to perform ... developed by ndd Medical Technologies , Inc. ... in hospital-based labs.  Thanks to ndd,s EasyOne PRO ® , ARL ... can get any needed testing done in the comfort of her ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern Californian, Dr. Omkar Marathe ... from the David Geffen School of Medicine at UCLA. He trained in Internal Medicine ... his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he had the ...
(Date:6/25/2016)... , ... June 25, 2016 , ... On Friday, June ... a Bronze Wellness at Work award to iHire in recognition of their exemplary accomplishments ... of the 7th annual Maryland Workplace Health & Wellness Symposium at the BWI Marriott ...
(Date:6/24/2016)... ... 2016 , ... A recent article published June 14 on E ... goes on to state that individuals are now more comfortable seeking to undergo not ... as calf and cheek reduction. The Los Angeles area medical group, Beverly Hills Physicians ...
(Date:6/24/2016)... ... June 24, 2016 , ... June 19, 2016 is World Sickle ... chronic pain and the benefits of holistic treatments, Serenity Recovery Center of ... Sickle Cell Disease. , Sickle Cell Disease (SCD) is a disorder of the red ...
(Date:6/24/2016)... ... June 24, 2016 , ... The ... in Dallas that it will receive two significant new grants to support its ... PHA marked its 25th anniversary by recognizing patients, medical professionals and scientists for ...
Breaking Medicine News(10 mins):